Monograph Details
|
|
Musculoskeletal Disorders
> Muscle spasms
|
|
NORFLEX INJECTION |
| Manufacturer |
|
Graceway Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Anticholinergic muscle relaxant (central). |
| Generic Name |
|
Orphenadrine citrate 60mg; per 2mL; contains sulfites. |
| Also |
|
• NORFLEX
|
| Indications |
|
Painful musculoskeletal conditions. |
| Children |
|
Not recommended. |
| Adults |
|
60mg IM or IV every 12 hrs. |
| Contraindications |
|
Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis. |
| Precautions |
|
Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone. |
| Adverse Reactions |
|
Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset. |
| How Supplied |
Tabs—100, 500
Amps (2mL)—6 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
